Patents by Inventor Michael Brian Bass

Michael Brian Bass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DKR polypeptides
    Patent number: 7723478
    Abstract: Disclosed are nucleic acid molecules encoding novel DKR polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: May 25, 2010
    Assignee: Amgen Inc.
    Inventors: Michael Brian Bass, John Kevin Sullivan, Lars Eyde Theill, Daguang Wang
  • Tumor endothelial marker 7-alpha molecules and uses thereof
    Publication number: 20090053763
    Abstract: The present invention provides Tumor Endothelial Marker 7? (TEM7?) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM7? polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TEM7? polypeptides.
    Type: Application
    Filed: March 10, 2008
    Publication date: February 26, 2009
    Applicant: Amgen, Inc.
    Inventors: Todd Juan, Michael Brian Bass, Jonathan Daniel Oliner
  • Antibodies to cyclin E2 protein
    Patent number: 7455963
    Abstract: Disclosed are nucleic acid molecules encoding cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: July 28, 2005
    Date of Patent: November 25, 2008
    Assignee: Amgen Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Antibodies to cyclin E2 protein
    Patent number: 6943238
    Abstract: Disclosed are nucleic acid molecules encoding novel cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: September 13, 2005
    Assignee: Amgen, Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Tumore endothelial market 7alpha molecules and uses thereof
    Publication number: 20030092025
    Abstract: The present invention provides Tumor Endothelial Marker 7&agr; (TEM7&agr;) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM7&agr; polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TEM7&agr; polypeptides.
    Type: Application
    Filed: May 28, 2002
    Publication date: May 15, 2003
    Applicant: Amgen, Inc., A Corporation of the State of Delaware
    Inventors: Todd Juan, Michael Brian Bass, Jonathan Daniel Oliner
  • Antibodies to cyclin E2 protein
    Publication number: 20030078370
    Abstract: Disclosed are nucleic acid molecules encoding novel cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Application
    Filed: October 4, 2002
    Publication date: April 24, 2003
    Applicant: Amgen Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Interleukin-1 receptor antagonist-related molecules and uses thereof
    Publication number: 20030004106
    Abstract: The present invention provides novel Interleukin-1 Receptor Antagonist-Related (IL-1ra-R) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing IL-1ra-R polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IL-1ra-R polypeptides.
    Type: Application
    Filed: May 6, 2002
    Publication date: January 2, 2003
    Applicant: Amgen, Inc., A Corporation of the State of Delaware
    Inventors: Christiaan M. Saris, Jennifer Giles, Sharon X. Mu, Min Xia, Michael Brian Bass, Roger Craveiro
  • Novel DKR polypeptides
    Publication number: 20020161178
    Abstract: Disclosed are nucleic acid molecules encoding novel DKR polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Application
    Filed: October 9, 2001
    Publication date: October 31, 2002
    Applicant: Amgen Inc.
    Inventors: Michael Brian Bass, John Kevin Sullivan, Lars Eyde Theill, Daguang Wang
  • Fibroblast growth factor-like molecules and uses thereof
    Publication number: 20020037557
    Abstract: The present invention provides Fibroblast Growth Factor-Like (FGF-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGF-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGF-L polypeptides.
    Type: Application
    Filed: March 13, 2001
    Publication date: March 28, 2002
    Applicant: Amgen, Inc.
    Inventors: Shuqian Jing, Michael Brian Bass
  • DKR polypeptides
    Patent number: 6344541
    Abstract: Disclosed are nucleic acid molecules encoding novel DKR polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: September 25, 1998
    Date of Patent: February 5, 2002
    Assignee: Amgen Inc.
    Inventors: Michael Brian Bass, John Kevin Sullivan, Lars Eyde Theill, Daguang Wang
  • Cyclin E genes and proteins
    Patent number: 6165753
    Abstract: Disclosed are nucleic acid molecules encoding novel cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: December 26, 2000
    Assignee: Amgen Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Cyclin E genes and proteins
    Patent number: 5973119
    Abstract: Disclosed are nucleic acid molecules encoding novel cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: October 26, 1999
    Assignee: Amgen Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson